Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Heikki Joensuu, M.D
Woman and Man Max 99 years
Heikki Joensuu, M.D., prof
Update Il y a 5 ans
Boron Neutron Capture Therapy (BNCT) as Treatment of Glioblastoma
Boron Neutron Capture Therapy (BNCT) is an experimental radiation therapy technique that is based on the principle of irradiating boron atoms with neutrons. When neutrons have relatively l...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
Heikki Joensuu, M.D
Update Il y a 5 ans
Adjuvant Trastuzumab, Pertuzumab Plus Docetaxel in the Treatment of Early HER2-positive Breast Cancer
This randomized clinical trial compares two systemic treatments for HER2-positive breast cancer. The treatments are given either prior to breast surgery (as neoadjuvant treatment) or after...
Country
None
organs
None
Specialty
None
Opened trial
More information
Woman and Man Max 99 years
Heikki Joensuu, M.D
Update Il y a 5 ans
Study Comparing 12 Months Versus 36 Months of Imatinib in the Treatment of Gastrointestinal Stromal Tumor (GIST)
In this study, patients who have been diagnosed with gastrointestinal stromal tumor (GIST) will be randomly allocated in a 1:1 ratio to receive imatinib (Gleevec) either for 12 or for 36 m...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Heikki Joensuu, M.D., Ph.D
Update Il y a 5 ans
Radiation Therapy as Palliative Treatment of GIST
Gastrointestinal stromal tumors (GISTs) are generally considered resistant to radiation, but no prospective trials addressing efficacy and tolerability of radiation therapy have been carri...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Heikki Joensuu, M.D
Update Il y a 5 ans
PTK787/ZK222584 in the Treatment of Metastatic Gastrointestinal Stromal Tumors Resistant to Imatinib
This study evaluates the safety and efficacy of a novel tyrosine kinase inhibitor, PTK787/ZK222584, in the treatment of GIST (gastrointestinal stromal tumor) that is resistant to imatinib ...
Country
Finland
organs
None
Specialty
None
Closed trial
More information